Enterococcal meningitis caused by Enterococcus casseliflavus. First case report

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Iaria, Chiara ^a   Stassi, Giovanna ^a   Costa, Gaetano Bruno ^a   Di Leo, Rita ^a   Toscano, Antonio ^a   Cascio, Antonio ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPICILLIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DEXAMETHASONE; GENTAMICIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METHOTREXATE; NORFLOXACIN; PENICILLIN G; STEROID; STREPTOMYCIN; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; AWARENESS; BACTERIAL MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID EXAMINATION; DIARRHEA; DISEASE DURATION; ENTEROCOCCUS CASSELIFLAVUS; FEMALE; FEVER; GRAM STAINING; HOSPITAL ADMISSION; HUMAN; ITALY; NONHUMAN; PHYSICAL EXAMINATION; RHEUMATOID ARTHRITIS; STUPOR; VOMITING;

AGED; AMPICILLIN; ANTI-BACTERIAL AGENTS; CEREBROSPINAL FLUID; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; SIGMOID DISEASES; SULBACTAM; THIENAMYCINS;

EID: 25444517096     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-3     Document Type: Article

References (14)

1. Pintado V, Cabellos C, Moreno S, Meseguer MA, Ayats J, Viladrich PF: Enterococcal meningitis: a clinical study of 39 cases and review of the literature. Medicine (Baltimore) 2003, 82:346-364.
2. Gascon F, Castano MA, Gonzalez A, Cordon MD: Endocarditis due to Enterococcus casseliflavus. Enferm Infecc Microbiol Clin 2003, 21:275-276.
3. Ratanasuwan W, Iwen PC, Hinrichs SH, Rupp ME: Bacteremia due to motile Enterococcus species: clinical features and outcomes. Clin Infect Dis 1999, 28:1175-1177.
4. Reid KC, Cockerill IF, Patel R: Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis 2001, 32:1540-1546.
5. Choi SH, Lee SO, Kim TH, et al.: Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases. Clin Infect Dis 2004, 38:53-61.
6. Kurup A, Tee WS, Loo LH, Lin R: Infection of central nervous system by motile Enterococcus: first case report. J Clin Microbiol 2001, 39:820-822.
7. Takayama Y, Sunakawa K, Akahoshi T: Meningitis caused by Enterococcus gallinarum in patients with ventriculoperitoneal shunts. J Infect Chemother 2003, 9:348-350.
8. Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K: Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). J Clin Microbiol 1997, 35:3166-3170.
9. Murray BE: Vancomycin-resistant enterococci. Am J Med 1997, 102:284-293.
10. Leclercq R, Courvalin P: Resistance to glycopeptides in enterococci. Clin Infect Dis 1997, 24:545-554.
11. Fazal BA, Turett GS, Chilimuri SS, Mendoza CM, Telzak EE: Community-acquired enterococcal meningitis in an adult. Clin Infect Dis 1995, 20:725-726.
12. Van Horn KG, Rodney KM: Colonization and microbiology of the motile enterococci in a patient population. Diagn Microbiol Infect Dis 1998, 31:525-530.
13. Gordts B, Van Landuyt H, Ieven M, Vandamme P, Goossens H: Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol 1995, 33:2842-2846.
14. Edlund C, Barkholt L, Olsson-Liljequist B, Nord CE: Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis 1997, 25:729-732.